‐Metformin and sitagliptin combination therapy is effective for PCOS with insulin resistance through upregulation of lncRNA‐H19. To summarize, co‐treatment induced H19 expression via suppressing the PI3K/AKT‐DNMT1 pathway. Here, AKT1 is linked to polycystic ovary syndrome.